Long term analysis of microbiological isolates and antibiotic susceptibilities in acute-onset postoperative endophthalmitis: a UK multicentre study
- PMID: 39939392
- PMCID: PMC12089534
- DOI: 10.1038/s41433-025-03673-w
Long term analysis of microbiological isolates and antibiotic susceptibilities in acute-onset postoperative endophthalmitis: a UK multicentre study
Abstract
Objectives: To review the trend of microbial isolates for postoperative endophthalmitis (POE) in the United Kingdom (UK) and determine the sensitivity to current empirical intravitreal antibiotic treatment.
Methods: We conducted a long term multicentre consecutive case review of POE across 3 geographically distant tertiary eye centres in the UK: Sunderland Eye Infirmary (2000-2022), Oxford Eye Hospital (2016-2022), and Southampton General Hospital (2016-2022). Data on the microbial samples taken and results including sensitivities to antibiotics agents given were collected. Poisson regression was used to analyse microbial trends and outcomes were considered statistically significant at a level of p < 0.05.
Results: 179 consecutive eyes of 177 patients with POE met our inclusion criteria. The most common primary procedure was phacoemulsification and IOL insertion followed by intravitreal injections. 104 (58.1%) were culture positive and most were Gram-positive bacteria (85, 81.7%). The microbial trend consistently showed Staphylococcus epidermidis and unspecified coagulase-negative Staphylococci to be the most prevalent pathogens. Poisson regression showed no statistically significant change in any of the bacterial isolates over our study period. Antibiotic sensitivity data was available for 74% of the culture positive samples (77/104). All Gram-positive bacteria (68/68, 100%) and most (8/9, 88.9%) Gram-negative bacteria were sensitive to the empirical antibiotics (Vancomycin and Ceftazidime/Amikacin) given at presentation.
Conclusions: Most of the bacterial isolates causing POE in the UK are Gram-positive bacteria, and the trend has remained stable over more than two decades. Current empirical treatment with intravitreal Vancomycin and Ceftazidime/Amikacin provides effective broad coverage for the vast majority of cases.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: DHS has received consulting fees from Alcon, Gyroscope Therapeutics (a Novartis company), Alimera, Complement therapeutics, BVI, and Roche, and research funding from Alcon, Gyroscope Therapeutics, Boehringer Ingelheim, DORC, Roche, and Bayer – all unrelated to this project. The other authors declare that they have no conflict of interest.
Figures
Similar articles
-
Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases.Curr Eye Res. 2017 Mar;42(3):443-447. doi: 10.1080/02713683.2016.1188118. Epub 2016 Jun 27. Curr Eye Res. 2017. PMID: 27347700
-
Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review.Br J Ophthalmol. 2014 Nov;98(11):1492-7. doi: 10.1136/bjophthalmol-2014-305030. Epub 2014 Jun 17. Br J Ophthalmol. 2014. PMID: 24939423
-
Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.Am J Ophthalmol. 2016 May;165:16-22. doi: 10.1016/j.ajo.2016.02.017. Epub 2016 Feb 26. Am J Ophthalmol. 2016. PMID: 26921804 Free PMC article.
-
Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.Ophthalmology. 2014 Aug;121(8):1634-42. doi: 10.1016/j.ophtha.2014.02.001. Epub 2014 Apr 2. Ophthalmology. 2014. PMID: 24702755 Review.
-
Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.Br J Ophthalmol. 2016 Apr;100(4):446-52. doi: 10.1136/bjophthalmol-2015-307722. Epub 2015 Dec 23. Br J Ophthalmol. 2016. PMID: 26701686 Free PMC article. Review.
References
-
- Behndig A, Cochener B, Güell JL, Kodjikian L, Mencucci R, Nuijts RM, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421–31. - PubMed
-
- Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM, et al. Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution. J Cataract Refract Surg. 2015;41:58–66. - PubMed
-
- Daien V, Papinaud L, Gillies MC, Domerg C, Nagot N, Lacombe S, et al. Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. JAMA Ophthalmol. 2016;134:810–6. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous